GRAL — GRAIL, Inc.

Nasdaq · Health Care · Health Care Providers & Services · CIK 1699031 ·
Last close
$68.96
Market Cap
$2.96B
52W High
$72.06
52W Low
$41.53
ADV30
582,750
Next earnings
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 40,785,000 -14,307,000 -135,765,000 -93,187,000 2,803,474,000 69,344,000 302,788,000
Dec 2025 43,597,000 -11,136,000 -124,411,000 -99,176,000 2,922,015,000 249,727,000 344,153,000
Sep 2025 36,194,000 -13,733,000 -125,291,000 -88,977,000 2,601,031,000 126,892,000 361,068,000
Jun 2025 35,544,000 -17,775,000 -130,854,000 -113,985,000 2,702,551,000 127,427,000 387,908,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-290,984,000
Investing CF
$-193,098,000
Financing CF
$423,321,000
CapEx
$-1,350,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-10.37
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-10,304,868,000
Inventory
$17,194,000
Receivables
$20,345,000
ST Investments
$753,761,000
EBIT TTM
$-516,321,000
Pretax Income TTM
$-515,615,000
Interest Exp TTM
Analysts
7

Yahoo Snapshot (yfinance, live)

Total Revenue
$156,120,000
EBITDA
$-360,496,000
Free Cash Flow
$-107,751,872
Enterprise Value
$2,111,490,944
Total Cash
$823,105,024
Total Debt
$51,030,000
Shares Out
42,916,593
Trailing EPS
$-10.30
Book Value
$60.79
ROE
-16.1%
ROA
-11.4%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 147,172,000 -534,163,000 -408,351,000 2,922,015,000 344,153,000 -299,007,000
Dec 2024 125,595,000 -768,222,000 -2,027,005,000 2,983,307,000 479,902,000 -577,156,000
Dec 2023 93,105,000 -796,916,000 -1,465,685,000 3,913,814,000 267,627,000 -595,800,000
Dec 2022 55,550,000 -742,459,000 -5,399,098,000 4,937,986,000 291,825,000 -561,313,000

TTM Snapshot

Revenues TTM
$28,652,000
NetIncome TTM
$-125,688,000
OpCashFlow TTM
$0
Assets (Latest)
$2,983,307,000
Forward EPS
$-9.18

Peers — same industry

TickerNameMarket CapLastDaily %
NHC NATIONAL HEALTHCARE CORP $2.97B $190.00
LFST LifeStance Health Group, Inc. $2.89B $7.57
PRVA Privia Health Group, Inc. $2.80B $22.20
BKD Brookdale Senior Living Inc. $3.22B $13.48
CON Concentra Group Holdings Parent, Inc. $3.27B $25.53

News headlines (Yahoo Finance, 1h cache)

GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
2026-05-26 20:01 · Yahoo
GRAIL to Present at the 2026 Jefferies Global Healthcare Conference
2026-05-21 20:01 · Yahoo
GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead
2026-05-17 16:02 · Yahoo
How The GRAIL (GRAL) Narrative Is Shifting After NHS Galleri Results And Reimbursement Questions
2026-05-08 10:13 · Yahoo
GRAIL Q1 Earnings Call Highlights
2026-05-06 00:38 · Yahoo
GRAIL Reports First Quarter 2026 Financial Results
2026-05-05 20:01 · Yahoo
GRAIL to Present at the BofA Securities 2026 Health Care Conference
2026-04-30 20:01 · Yahoo
Will Ultragenyx (RARE) Report Negative Q1 Earnings? What You Should Know
2026-04-28 14:00 · Yahoo
GRAIL to Announce First Quarter 2026 Financial Results
2026-04-22 20:01 · Yahoo
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting
2026-04-21 20:53 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.